Pharming Group (NASDAQ:PHAR – Get Free Report)‘s stock had its “buy” rating reissued by HC Wainwright in a research report issued on Monday, Benzinga reports. They presently have a $37.00 price objective on the stock. HC Wainwright’s target price points to a potential upside of 230.06% from the stock’s previous close. A number of other […]

Baldwin Insurance Group (NASDAQ:BWIN – Get Free Report)‘s stock had its “market perform” rating reaffirmed by investment analysts at William Blair in a report released on Monday, Benzinga reports. Other research analysts also recently issued reports about the stock. Morgan Stanley set a $28.00 price target on shares of Baldwin Insurance Group in a research […]

Corbus Pharmaceuticals (NASDAQ:CRBP – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a note issued to investors on Monday, Benzinga reports. They currently have a $35.00 price objective on the biopharmaceutical company’s stock. HC Wainwright’s price target suggests a potential upside of 321.94% from the stock’s current […]

Definium Therapeutics (NASDAQ:DFTX – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at Needham & Company LLC in a research report issued on Monday, Benzinga reports. They presently have a $66.00 price target on the stock. Needham & Company LLC’s price objective would suggest a potential upside of 69.71% from the […]